JPRN-UMIN000003859已完成未知
The assessment of the appropriate duration of early intervention for Japanese cedar pollinosis by a leukotriene-receptor antagonist - The assessment of the appropriate duration of early intervention for Japanese cedar pollinosis by a leukotriene-receptor antagonist
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with disease which make objective evaluation difficult. *infection disease *nonallergic rhinitis *medicamentosa 2) Anti-allergy drug treatment within two weeks of study entry. 3) Patients who have received immunotherapy. 4) Allergic Rhinitis patients who underwent laser surgery and operation within 6 months. 5) Uncontrolled asthma patients 6) Patients who have the hypersensitivity to study drugs 7) Infectious diseases and mycosis, with no effective therapeutic drug. 8) Pregnant or lactating women and women with possibility of pregnancy. 9) Patients who were judged to be unsuitable for patient enrollment by their doctor.
研究者
相似试验
已完成
不适用
The assessment of the optimum timing of perioperative changing glovesColorectal diseaseJPRN-UMIN000018703Keio university school of medicine department of surgery200
尚未招募
Unknown
Assessment of ideal timing and effectiveness of left heart unloading using invasive hemodynamic monitoring in patients with cardiogenic shock who treated with venoarterial extracorporeal membrane oxygenatioSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0009225Chonnam National University Hospital50
招募中
不适用
Time taken to administer antibiotic in patients admitted in ICCTRI/2019/02/017409Dr Amarja Ashok Havaldar
招募中
2 期
Evaluation the effect of prolonging the duration of administration of Colistin infusion on the Colistin-induced nephrotoxicityIRCT20230225057533N1Arak University of Medical Sciences72
进行中（未招募）
1 期
Valoración de la eficacia a corto plazo de un extracto de Dermatophagoides pteronyssinus, valorado en unidades de masa y administrado por vía subcutánea, en el tratamiento del asma alérgico. Estudio randomizado, doble ciego controlado con placeboAsma alérgico perenne, con/sin síntomas de rinitis o rinoconjuntivitis, por sensibilización a Dermatophagoides pteronyssinus.EUCTR2005-005636-28-ESALK-ABELLÓ, S.A.